| 1. |
Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med, 2020, 26(5): 527-534.
|
| 2. |
陈相, 李耀浙, 傅扬扬等. 1990-2019年中国间质性肺疾病和肺结节病的疾病负担分析. 疾病监测, 2023, 38(4): 473-480.
|
| 3. |
Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol, 2016, 16(1): 220.
|
| 4. |
Suresh S, Kosmorsky GS, Lee MS. Isolated optic nerve sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 2017, 34(2): 179-183.
|
| 5. |
Stern BJ, Royal W 3rd, Gelfand JM, et al. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol, 2018, 75(12): 1546-1553.
|
| 6. |
段曼曼, 于世荣, 朱学娥, 等. 伴有眼部症状的皮下结节型结节病一例. 中国麻风皮肤病杂志, 2023, 39(7): 521-523.
|
| 7. |
张倩, 黄慧, 徐作军. 肺结节病的诊治进展. 临床内科杂志, 2020, 37(10): 684-688.
|
| 8. |
Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax. 1995, 50(5): 555-559.
|
| 9. |
Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Urol Clin North Am, 2000, 27(2): 275-285.
|
| 10. |
Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart, 2016, 102(3): 184-190.
|
| 11. |
Hamzeh N, Steckman DA, Sauer WH, et al. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol, 2015, 12(5): 278-288.
|
| 12. |
中华医学会呼吸病学分会间质性肺疾病学组, 中国医师协会呼吸医师分会间质性肺疾病工作委员会, 等. 中国肺结节病诊断和治疗专家共识. 中华结核和呼吸杂志, 2019, 42(9): 685-693.
|
| 13. |
Leonhard SE, Fritz D, Eftimov F, et al. Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study. Medicine (Baltimore), 2016, 95(14): e3277.
|
| 14. |
Locke AH, Gurin MI, Sabe M, et al. Arrhythmia in cardiac sarcoidosis. Cardiol Rev, 2021, 29(3): 131-142.
|
| 15. |
Niederer RL, Sims JL. Utility of screening investigations for systemic sarcoidosis in undifferentiated uveitis. Am J Ophthalmol, 2019, 206: 149-153.
|
| 16. |
王秀燕, 高建梅, 张红, 等. 以胸腔积液为首发表现的结节病四例. 中国呼吸与危重监护杂志, 2022, 21(3): 185-188.
|
| 17. |
Leader JK, Warfel TE, Fuhrman CR, et al. Pulmonary nodule detection with low-dose CT of the lung: agreement among radiologists. AJR Am J Roentgenol, 2005, 185(4): 973-978.
|
| 18. |
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med, 2007, 357(21): 2153-2165.
|
| 19. |
Grumet P, Kodjikian L, de Parisot A, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev, 2018, 17(4): 331-343.
|
| 20. |
Niederer RL, Al-Janabi A, Lightman SL, et al. Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis. Am J Ophthalmol, 2018, 194: 82-87.
|
| 21. |
Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, et al. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol, 2020, 11: 1443.
|
| 22. |
Febvay C, Kodjikian L, Maucort-Boulch D, et al. Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases. Br J Ophthalmol, 2015, 99(10): 1372-1376.
|
| 23. |
Bilgin B, Bilgin MK, Erol S, et al. Prognosis of sarcoidosis and factors affecting prognosis. Sarcoidosis Vasc Diffuse Lung Dis, 2023, 40(4): e2023054.
|
| 24. |
龚金锋, 黄光. 神经结节病研究进展. 武警医学, 2018, 29(06): 638-642.
|
| 25. |
Fahim A, Mann JS. Pulmonary sarcoidosis: diagnostic and treatment update. Expert Rev Respir Med, 2014, 8(4): 493-501.
|
| 26. |
丁雁启, 李合友, 袁雪芹. 结节病四例诊治体会. 中国呼吸与危重监护杂志, 2016, 15(2): 176-178.
|
| 27. |
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, et al. Refractory sarcoidosis: a review. Ther Clin Risk Manag, 2020, 16: 323-345.
|
1/5
WeChat